Curbstone Financial Management Corp’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
6,532
+2,338
+56% +$350K 0.17% 117
2026
Q1
$641K Sell
4,194
-150
-3% -$23K 0.12% 150
2025
Q4
$599K Hold
4,344
0.11% 147
2025
Q3
$557K Sell
4,344
-100
-2% -$12.2K 0.11% 157
2025
Q2
$538K Buy
4,444
+188
+4% +$21.2K 0.11% 161
2025
Q1
$474K Hold
4,256
0.1% 172
2024
Q4
$414K Buy
4,256
+212
+5% +$22.6K 0.09% 182
2024
Q3
$465K Hold
4,044
0.1% 175
2024
Q2
$431K Buy
+4,044
New +$406K 0.09% 180
2024
Q1
Sell
-4,094
Closed -$413K 191
2023
Q4
$413K Hold
4,094
0.09% 185
2023
Q3
$417K Hold
4,094
0.1% 174
2023
Q2
$413K Buy
+4,094
New +$409K 0.1% 176

Other funds holding NVS

Curbstone Financial Management Corp's NVS Position: Q2 2026 in Review

Curbstone Financial Management Corp increased its Novartis (NVS) stake by 56% in Q2 2026, buying an estimated $350K and bringing the position to 6,532 shares worth $1.02M. The position accounts for 0.17% of the portfolio, ranked #117.

Curbstone Financial Management Corp first reported a position in NVS in Q2 2023 and has held it in 12 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Curbstone Financial Management Corp held 6,532 shares of Novartis worth $1.02M as of Q2 2026.
  • Curbstone Financial Management Corp bought 2,338 Novartis shares in Q2 2026, an estimated $350K.
  • Novartis made up 0.17% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #117 holding.
  • Curbstone Financial Management Corp first reported a position in Novartis in Q2 2023 and has held it in 12 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.